£53.00

It has never been this cheap. We have no record of a lower price.

£53 today · cheaper than every other day in the last 3 months

Inflammation indices in prostate cancer patients: Inflammation indices as prognostic and predictive factors in prostate cancer patients

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 30 days · 30 data points (no recent data)

Historical
Generating forecast…
£53.00 £50.35 £51.41 £52.47 £53.53 £54.59 £55.65 11 August 2026 18 August 2026 25 August 2026 01 September 2026 09 September 2026
View at Amazon ↗

Price data last checked 61 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 30 days • 1 price levels

Days at Price
30 days 0 8 15 23 30 £53 Days at Price

Price Analysis

Most common price: £53 (30 days, 100.0%)

Price range: £53 - £53

Price levels: 1 different prices over 30 days

Description
Prostate cancer is the leading cause of worldwide incidence of neoplastic disease. On the other hand, inflammation plays a vital role in the spread of cancer cells. The aim of this work was to determine whether NLR and PLR inflammatory indices in prostate cancer patients have a prognostic value for survival and/or predictive of the effect of CIMAVAX-EGF and Nimotuzumab immunotherapy treatments. The results of the present investigation showed that the NLR index decreased and the PLR index increased over time for all treatments. A low NLR proved to be prognostic for the survival of patients in the CIMAvax-EGF trial. Also, the PLR index showed that its predictive value is due to the fact that patients with high PLR treated with Nimotuzumab have a longer survival than controls. The present work shows that the NLR and PLR indices are an accessible and cost-effective laboratory tool that provides prognostic and predictive information for prostate cancer and associated immunotherapeutic treatments.

Product Specifications
Format
paperback
ASIN
6206653242
Category
Books > Subjects > Biography > Medical, Legal & Social Sciences > Anthropology & Sociology
Domain
Amazon UK
Release Date
09 November 2023
Listed Since
10 November 2023

Barcode

No barcode data available

Similar Products You Might Like

Prostate Cancer: Symptoms, Diagnosis & Treatment
86% match

Prostate Cancer: Symptoms, Diagnosis & Treatment

£87.68 07 Nov 2026
Diagnosis and Clinical Management of Prostate Cancer
85% match

Diagnosis and Clinical Management of Prostate Cancer

£113.69 27 Oct 2026
A New Approach to Diagnosis and Treatment of Prostate Cancer
84% match

A New Approach to Diagnosis and Treatment of Prostate Cancer

£110.26 27 Oct 2026
Epidemiological and pathological study of testicular cancer: at a cancer center
84% match

Epidemiological and pathological study of testicular cancer: at a cancer center

£47.98 27 Aug 2026
Cancer
84% match

Cancer

£160.28 27 Oct 2026
Cancer Exposomics and Environmental Influences on Carcinogenesis
84% match

Cancer Exposomics and Environmental Influences on Carcinogenesis

£163.40 27 Oct 2026
Chronic kidney disease overview
83% match

Chronic kidney disease overview

£68.00 04 Nov 2026
Ovarian Cancer: Progression, Diagnosis and Treatment
83% match

Ovarian Cancer: Progression, Diagnosis and Treatment

£111.48 27 Oct 2026
Tumor Markers in Head and Neck Oncology
83% match

Tumor Markers in Head and Neck Oncology

LAP Lambert Academic Publishing

£53.00 27 Oct 2026
Arthritis: Managing Inflammation and Pain
82% match

Arthritis: Managing Inflammation and Pain

£110.90 27 Oct 2026
ORAL HYGIENE AND SYSTEMIC DISEASE
82% match

ORAL HYGIENE AND SYSTEMIC DISEASE

£66.00 24 Oct 2026
Cáncer vulvar
82% match

Cáncer vulvar

£52.00 23 Oct 2026
Laryngeal Cancer: Risk Factors, Symptoms and Treatment
82% match

Laryngeal Cancer: Risk Factors, Symptoms and Treatment

Price unavailable
Cytokine and Chemokine Networks in Cancer
82% match

Cytokine and Chemokine Networks in Cancer

Springer

£142.07 22 Oct 2026
Lung Cancer: From Diagnosis to Treatment
82% match

Lung Cancer: From Diagnosis to Treatment

£119.26 27 Oct 2026
The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis
82% match

The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis

£97.69 27 Oct 2026
82% match

Percutaneous Prostate Cryoablation

£70.00 27 Aug 2026
Inflammation, Aging and Cancer: Biological Injustices to Molecular Village of Immunity that Guard Health
82% match

Inflammation, Aging and Cancer: Biological Injustices to Molecular Village of Immunity that Guard Health

Springer

£109.80 24 Oct 2026
Diagnosis and surgical treatment of chronic pancreatitis: 2nd ed.
82% match

Diagnosis and surgical treatment of chronic pancreatitis: 2nd ed.

£93.25 09 Sep 2026
Personalized Cancer Medicine through Multiomics
82% match

Personalized Cancer Medicine through Multiomics

Elsevier

£157.99 22 Oct 2026
Cancer and Immunotherapy
82% match

Cancer and Immunotherapy

£110.93 29 Oct 2026
Immunotherapy for Gastrointestinal Cancer
82% match

Immunotherapy for Gastrointestinal Cancer

Springer

£73.14 21 Oct 2026
Prostate Cancer
82% match

Prostate Cancer

IntechOpen

£94.99 29 Oct 2026
Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation
82% match

Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation

Springer

£80.67 21 Oct 2026